Form 4: Exelixis EVP and CFO Christopher J. Senner Reports Acquisition of Performance-Based Restricted Stock Units

Christopher J. Senner, EVP and CFO of Exelixis, reports the acquisition of performance-based restricted stock units and adjustments to holdings in common stock and 401(k).

Summary

• On March 31, 2025, Christopher J. Senner, the EVP and CFO of Exelixis, Inc., reported changes in beneficial ownership of company stock.
• Senner acquired 170,009 performance-based restricted stock units (PSUs) under the 2017 Equity Incentive Plan.
• These PSUs vest if the volume-weighted average closing price of Exelixis common stock equals or exceeds $60 per share for 90 consecutive calendar days within a five-year period, and if Senner remains employed through the fifth anniversary of the grant date.
• Senner directly owns 1,009,264 shares of common stock, including shares issuable upon vesting of restricted stock units (RSUs) and PSUs.
• He also indirectly owns 2,723 shares of common stock through the Exelixis, Inc. 401(k) Plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of PSUs suggests confidence in the company's future performance, but it's a standard executive compensation practice.

Positives

• The acquisition of performance-based restricted stock units aligns the executive's interests with the company's performance, incentivizing efforts to increase the stock price.
• The vesting conditions tied to a $60 stock price target suggest confidence in the company's future growth potential.

Risks

• The vesting of the PSUs is contingent on achieving a specific stock price target and continued employment, introducing uncertainty regarding the actual realization of these units.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting conditions of the PSUs imply an expectation of future stock price appreciation.

Industry Context

Form 4 filings are standard disclosures for company insiders and provide transparency regarding their transactions in the company's stock. This filing indicates the executive's compensation structure and alignment with shareholder interests.

Comparison to Industry Standards

• Performance-based equity compensation is a common practice among publicly traded companies, particularly in the biotechnology sector, to incentivize executives to achieve specific performance goals.
• The vesting conditions, such as the $60 stock price target, are specific to Exelixis and reflect the company's internal targets and expectations.
• Comparing the size of the PSU grant to those of executives at comparable biotechnology companies would provide further context on the competitiveness of Exelixis's compensation practices.

Stakeholder Impact

• The acquisition of PSUs aligns the executive's interests with shareholders, potentially driving efforts to increase shareholder value.
• The vesting conditions tied to stock price performance could positively impact shareholder returns if the targets are achieved.

Key Dates

Keywords

Exelixis, Senner, Performance-Based Restricted Stock Units, PSU, RSU, Beneficial Ownership, Form 4, Equity Incentive Plan, Stock Options, CFO